Amy W. Schulman - 13 Mar 2025 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Director
Signature
By: Brett Budzinski, Attorney-in-Fact For: Amy Schulman
Issuer symbol
ALNY
Transactions as of
13 Mar 2025
Net transactions value
+$360,828
Form type
4
Filing time
14 Mar 2025, 16:16:13 UTC
Previous filing
27 Jun 2024
Next filing
12 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $360,828 +2,750 +33% $131.21 11,186 13 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Stock Option (right to buy) Options Exercise $0 -2,750 -100% $0.000000 0 13 Mar 2025 Common Stock 2,750 $131.21 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options exercised and held by the reporting person were due to expire on June 1, 2025.
F2 The stock option was fully vested as of June 1, 2016.